Intersect ENT, Inc. Accounts Receivable, Credit Loss Expense (Reversal)
Intersect ENT, Inc. reported Accounts Receivable, Credit Loss Expense (Reversal) of $332.00 thousand for the 12-month period ending 2021-12-31, per its 10-K filed 2022-03-08.
Discontinued › Expense Statement › Operating Expenses
us-gaap:ProvisionForDoubtfulAccounts · last filed 2022-03-08
- Intersect ENT, Inc. accounts receivable, credit loss expense (reversal) for fiscal 2021 was $332.00K, a 50.23% increase from fiscal 2020.
- Intersect ENT, Inc. accounts receivable, credit loss expense (reversal) for fiscal 2020 was $221.00K, a 135.11% increase from fiscal 2019.
- Intersect ENT, Inc. accounts receivable, credit loss expense (reversal) for fiscal 2019 was $94.00K.
| Period end | Accounts Receivable, Credit Loss Expense (Reversal) 12 month |
|---|---|
| 2021-12-31 | $332.00K 10-K · filed 2022-03-08 |
| 2020-12-31 | $221.00K 10-K · filed 2022-03-08 |
| 2019-12-31 | $94.00K 10-K · filed 2022-03-08 |